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Introduction
In recent years there has been observed a rapid expan-
sion in the development of Cu(II) complexes as important 
bioactive compounds as potential drugs for therapeutic 
intervention in various diseases. Their properties as radi-
opharmaceuticals (Iakovidis et  al. 2011), antimicrobial 
(Jimenez-Garrido et  al. 2005), anti-inflammatory (Govind 
and Rajesh 1992), antitumor (Travnicek et al. 2001) agents, 
enzyme inhibitors (Lachowicz et  al. 2015) or chemical 
nucleases (Efthimiadou et al. 2007) have been reported for 
numerous Cu(II) complexes.
A wide role of transition metal ions in biological pro-
cesses induces the intensive development of studies allow-
ing to the characteristic of copper homeostasis. These 
studies are performed by the using of the biomimetics 
mimicking the structure or activity of the naturally occur-
ring systems. Copper plays significant role in the biologi-
cal systems where is mainly bound to the peptides or pro-
teins. That interaction with peptide/protein is the base of 
their transport in living systems and storage. Moreover, this 
interaction is responsible for the activity of number of met-
alloperoteins or their toxicity.
The binding of copper metal ions by peptide may 
be realized by coordination to donors from the peptide 
chain: nitrogen of the N-terminal amino group or peptide 
bond and oxygen form the C-terminal carboxylate group 
or peptide bond. However, in the living systems, it takes 
place mainly to donor atoms of side chains of the amino 
acid residues e.g. His or Asp (Kozlowski et al. 2005; Sigel 
and Martin 1982; Sovago et al. 2012). The involvement of 
donors from the side chains group of amino acid residues 
is found inter alia in the active centers of metalloenzymes 
with one (e.g. plastocyanin, nitrite reductase, quercetinase) 
or two metal ions (e.g. tyrosinase, hemocyanin, cytochrome 
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c oxidase) (MacPherson and Murphy 2007; McCleverty 
and Meyer 2004).
Several authors have brought the attention to the redox 
properties (Fragoso et  al. 2015) as well as antioxidant/
superoxide scavenging of Cu(II) complexes (Fragoso et al. 
2015; Pap et al. 2011). The copper (II) complexes exhibit 
antioxidant properties due to their capacity to mimic the 
activity of the superoxide dismutase enzyme. The mono-
nuclear and dinuclear copper (II) complexes with multi-
histidine peptides are good functional models of metallo-
enzymes center e,g, the Cu,ZnSOD (Bonomo et  al. 1998; 
Timari et al. 2011; Valensin et al. 2009) and phenoloxidase 
enzyme (Matusiak et  al. 2014). Superoxide dismutase, 
Cu,ZnSOD is a metalloprotein where the copper is pre-
sent in the catalytic center and undergoes reduction–oxida-
tion cycling during the dismutation of superoxide anion. 
Although zinc ion is not involved in redox cycle, it facili-
tates the oxidation step by maintaining the configuration 
of the active site (Agotegaray et  al. 2012). The schematic 
mechanism of superoxide dismutation is present on Fig. 1.
The cyclopeptides are the subtype of the peptides having 
characteristic cyclic motif in their structure which may be 
obtained by formation of the disulphide bond between two 
Cys residues or formation of the peptide bond. The cycliza-
tion of the peptide chain influences significantly the abili-
ties of the peptides (Bockus et  al. 2013; Hill et  al. 2014) 
e.g. the peptides with the cyclic structure are more stable in 
the biological conditions than the linear analogues (Kumar 
et  al. 2006; Roxin and Zheng 2012). Moreover the cyclic 
structure of the peptide chain makes it less flexible and 
influences the steric arrangement of the side chains groups 
(Hruby 1982; Hruby et  al. 1990) as well as coordination 
abilities (Brasun et al. 2004; Fragoso et al. 2013). The cop-
per (II) binding by cyclopeptides strongly depends on the 
acid–base properties of the side chain groups (Czapor et al. 
2011; Matera et  al. 2008), its optical isomerism (Matera 
et  al. 2008), number of His residues in the peptide chain 
as well as the size of the peptide ring (Brasuń et al. 2009). 
Moreover, the insertion of two Pro amino acid residues in 
their sequence allows for creating of two well defined bind-
ing sites for metal ions (Kotynia et  al. 2012, 2014). Our 
previous studies have shown that the presented cyclopep-
tide (Kotynia et al. 2014) as well as its analogue with the 
c(HKHPHKHP) sequence (Kotynia et al. 2012) are able to 
form di-copper complexes with the {2NIm, 2N−am} binding 
manner observed in the physiological range of pH. Based 
on previous studies we decided to characterize the abilities 
of cyclopeptide with the c(HKHGPG)2 sequence to form 




The synthesis of discussed peptide c(HKHGPG)2 have 
been described in details in the previously published article 
(Kotynia et al. 2014).
The Potentiometric Measurements
The potentiometric titration were performed on Molspin 
pH-meter system using a Mettler Toledo InLab®Micro 
combined electrode. The electrode was calibrated by titra-
tion hydrogen ion sample using HCl three times before 
each system. The KOH titrant (0.1 mol dm− 3) was added 
from a 0.250  ml micrometer syringe and the concentra-
tion was calibrated by weight titrations of standard materi-
als. All samples were titrated in thermostat vessel at 298 K 
Fig. 1  The schematic mecha-
nism of the metallo-active 
center of Cu,ZnSOD (Hart et al. 
1999; MacPherson and Murphy 
2007)
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over the pH range 2.5–11.5 under argon gas atmosphere. 
The ligand concentration was 8 × 10− 4 mol dm− 3 in solu-
tion the ionic strength was in 0.1 mol dm− 3 KCl. The sam-
ples with metals ion system were prepared by added equi-
molar amounts of  CuCl2 and  ZnCl2 solutions where final 
ratio Cu(II):Zn(II):L = 1:1:1. The stability constants of the 
proton and metal complexes were calculated from titration 
curves by the HYPERQUAD 2008 (written by Peter Gans, 
Protonic Software) computer program (Gans et  al. 1996). 
The standard deviations for each constants were com-
puted and refer to random errors only. They were a good 
indication of the importance of a particular species in the 
equilibrium.
The UV–Vis and CD Spectroscopic Measurements
The absorption spectra of complexes were recorded on Var-
ian Carry 50 Bio spectrophotometer in 1  cm path length 
quartz cells. All UV–Vis spectra were collected in the 
200–900 nm range. The spectroscopic measurements were 
carried out at 298 K, samples solutions were similar con-
centrations as in pH-metric titration. The circular dichroism 
(CD) spectra were recorded on a magnetic circular dichro-
ism JASCO J-1500 spectrometer in 230–800  nm range, 
using 1 cm cuvettes.
The Measurement of Cu,ZnSOD Activity
The in  vitro SOD activity of Cu(II)/Zn(II) cyclopep-
tide complexes was determined by the method of Beau-
champ et  al. (Beauchamp and Fridovich 1971). The tests 
were carried out at 25 °C, in samples containing Cu(II) 
and Zn(II) peptide complexes in different molar ratios in 
Tris–HCl buffer (25  mM, pH 7.4). The enzymatic assay 
contained (5 × 10− 5  mol  dm−3) nitroblue tetrazolium 
(NBT),  (10− 3  mol  dm−3) xanthine, and an appropriate 
amount of xanthine oxidase in order to cause a change in 
absorbance at 560 nm of about ΔA560 = 0.020 min− 1. The 
NBT reduction rate was measured in the presence and the 
absence of the investigated system for 300 s. The SOD-like 
activity was then expressed by the  IC50 values (the concen-
tration that causes 50% inhibition of NBT reduction).
Molecular Modelling
In order to propose the possible structure of investigated 
complexes we have examined tens of different conformers 
of  [ZnCuL]4+, [ZnCuH-1L]3+, [ZnCuH-2L]2+, [ZnCuH-
3L]+ species. Geometries of all complexes have been 
fully optimized using NDDO-type semiempirical method 
referred to as PM6 which offers reasonable compromise 
between accuracy and computational cost (Stewart 2009). 
As it has been shown by Stewart, in the case of many 
properties (including equilibrium geometries, electric-dipol 
properties and heats of formation) PM6 method improves 
substantially upon PM3 method. This method is also quite 
useful in determining structures of bioinorganic complexes 
with transition metals and modeling of proteins and metalo-
proteins (Stewart 2009). Geometry optimizations have been 
followed by evaluation of hessian matrix to confirm that 
obtained structures correspond to minima on the potential 
energy surface. To account for solvent effects (water solu-
tion) we have applied polarizable continuum model (PCM) 
(Cances et al. 1997; Tomasi et al. 2005, 1999). The lowest 
energy conformers obtained using the PM6 method were 
presented in the Fig.  4. All calculations have been per-
formed within unrestricted formalism using Gaussian 09 
suite of programs (Frisch et al. 2009).
Results
The Formation of Heteronuclear Cu(II)/Zn(II) 
Complexes
The analyzed cyclopeptide has two -GHKHG- binding sites 
potential for metal ions. The previous studies performed 
for the system with investigated peptide and double excess 
of Cu(II) ions have shown that it is able to form di-copper 
complexes. This process is observed above pH 6. Below 
this pH only mononuclear species, with imidazole donors 
involved in metal binding, exist in the system. Furthermore, 
in the physiological range of pH the dominant species is the 




mode for both copper (II) ions and it does not change with 
increasing of pH (Kotynia et al. 2014).
In the present manuscript we show the results of 
potentiometric and spectroscopic studies for the Cu(II)/
c(HKHGPG)2/Zn(II) system. The potentiometric results 
are presented in Table 1 and Fig. 2 whilst the spectroscopic 
data in Table  2. The investigated ligand is the  H6L acid 
with four His and two Lys amino acid residues protonated 
(Table 1; Fig. 2a). With increase of pH  [H5L]5+,  [H4L]4+, 
 [H3L]3+,  [H2L]2+ forms of the ligand appear in the system 
what can be assigned to the protons dissociation from the 
imidazoles of His residue. The formation of two last forms 
 [HL]+and [L] results by proton dissociation from side 
chains of both Lys residues.
The metal binding starts around pH 4 by complexation 
only copper (II) ions and formation two mononuclear com-
plexes:  [CuH4L]6+ and  [CuH2L]4+ (Fig.  2b). The stabili-
ties constants calculated for both complexes (Table 1) are 
comparable to the constants of corresponding complexes 
with the {2NIm} and {4NIm} binding modes, consecutively, 
which are found in the system with the Cu(II)-to-ligand 
molar ratio 1:1 (Table 1) (Kotynia et al. 2014). Due to the 
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low concentration of the  [CuH4L]6+ species, it was pos-
sible to obtain the spectroscopic parameters only for the 
 [CuH2L]4+ complex. The analysis of the potentiometric 
results for the metal ions—system shows, that at pH 2.9 
exists only free ligand (Fig.  2b) and the CD spectrum 
recorded at this pH significantly differs from the spectrum 
Table 1  The stability constants for c(HKHGPG)2 obtain from HYPERQUAD calculation and its Cu(II)/Zn(II) heteronuclear species with com-
parison with copper (II) mono- and di-nuclear complexes
The charges of species have been omitted to more clarity
logβ HL H2L H3L H4L H5L H6L 
10.26 ± 0.012 19.94 ± 0.009 27.00 ± 0.012 33.23 ± 0.015 39.20 ± 0.013 44.76 ± 0.014
logK NH2 (Lys) NH2 (Lys) NIm (His) NIm (His) NIm (His) NIm (His)
10.26 9.68 7.06 6.23 5.97 5.12
Cu (II) system (Kotynia et al. 2014) Cu(II)/Cu(II) system (Kotynia et al. 2014) Cu(II /Zn(II) system
Species logβ Species logβ Species logβ
  CuH4L 39.20   CuH4 39.20   CuH4L 38.88 ± 0.016
  CuH2L 29.99   CuH2L 29.99   CuH2L 29.82 ± 0.010
CuL 14.77   Cu2H-1L 14.54  ZnCuL 19.38 ± 0.018
 CuH-1L 5.54   Cu2H-2L 8.26  ZnCuH-1L 12.04 ± 0.015
 CuH-2L −4.57   Cu2H-3L −1.54  ZnCuH-2L 3.54 ± 0.020
 CuH-3L −14.69   Cu2H-4L −11.64  ZnCuH-3L −5.82 ± 0.022
 ZnCuH-4L −15.60 ± 0.021
ZnCuH-5L −26.19 ± 0.021
pK pK pK
 logβCuH4L − logβCuH2L 9.21  logβCuH4L  − logβCuH2L 9.21  logβCuH4L  − logβCuH2L 9.06
 logβCuH2L − logβCuL 15.25  logβCu2H-1L  − logβCu2H-2L 6.28  logβZnCuL  − logβZnCuH-1L 7.34
 logβCuL − logβCuH-1L 9.23  logβCu2H-2L  − logβCu2H-3L 9.80  logβZnCuH-1L  − logβZnCuH-2L 8.50
 logβCuH-1L− logβCuH-2L 10.11  logβCu2H-3L  − logβCu2H-4L 10.10  logβZnCuH-2L  − logβZnCuH-3L 9.36
 logβCuH-2L − logβCuH-3L 10.12  logβZnCuH-3L  − logβZnCuH-4L 9.78




























































Fig. 2  The distribution of species: a for free ligand c(HKHGPG)2. b Heteronuclear complexes formed in Cu(II)/c(HKHGPG)2/Zn(II) = 1:1:1 
system, depending on the pH
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obtained at pH 5.57. It strongly supports that the CD 
spectrum (at pH 5.57) can be attributed to the  [CuH2L]4+ 
complex. The presence of two CT bands: one negative at 
304 nm and second positive at 269 nm in the CD spectrum 
confirms the involvement only imidazole donors in copper 
(II) binding (Table 2; Fig. 3b).
With increase of pH, two protons dissociate and the first, 
heteronuclear  [CuZnL]4+ complex is formed. Its appear-
ance significantly influences the spectral abilities of the 
system, primarily the CD spectrum. Owing to the fact, that 
the Zn(II) cation is the  d10-metal ion and it is spectrophoto-
metrically silent, the changes in the spectral abilities of the 
Table 2  The UV–Vis and CD 
spectroscopic properties for 
complexes formed in Cu(II)/
c(HKHGPG)2/Zn(II) = 1:1:1 
system
The charges of species have been omitted to more clarity
a d – d transition, sh shoulder
b N− → Cu2+ charge transfer
c NIm→ Cu2+ charge transfer
pH Prevailing Cu(II) coordination mode UV–Vis CD
The percentage of species existing in each pH λ [nm] ε[dm3 cm mol−1] λ [nm] ∆ε 
 [dm3 cm mol− 1]




7.0 {2NIm, 2N−am} 547a 102 560.1a −0.11
603 sh 487.5a +0.14
43%—CuZnL, 343.3b −0.60
34%—CuH2L, 23%—CuZnH-1L 280.4 sh
252.0c +1.67
8.0 {2NIm, 2N−am} 537a 114 552.7a −0.17
609 sh 481.0a +0.15
63%—CuZnH-1L 343.8b −0.83
2%—CuH2L, 14%—CuZnL 280.4 sh
20%—CuZnH-2L, 1%—CuZnH-3L 244.1c +3.16
~11.0 {NIm, 3N−am} 530a 120 661.6a +0.25
618 sh 518.5a −0.31
72%—CuZnH-5L 343.3b −0.21




































Fig. 3  The a UV–Vis. b CD spectra of complexes in Cu(II)/c(HKHGPG)2/Zn(II) = 1:1:1 system, depending on the pH
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solution correspond to changes in the coordination sphere 
of Cu(II) ion. The appearance of the negative CT band at 
343 nm in CD spectrum obtained at pH 7 (Table 2; Fig. 3b) 
supports the involvement of amide nitrogens in copper (II) 
binding and the location of the main d–d band at 547 nm in 
UV–Vis spectrum shows binding of four nitrogens to the 
copper (II). Based on these facts the {2NIm, 2N−am} may be 
proposed for Cu(II) ion. On the other hand, there are two 
possibilities of Zn(II) ion binding in discussed complex: 
by one or two imidazole nitrogens. The value of corrected 
logβ* = 4.61, were logβ* = logβZnCuL–logβCuL, is compara-
ble for the stability constants of the Zn(II) complexes with 
two imidazole nitrogens bound to metal ion (Kallay et  al. 
2009; Valensin et  al. 2009). The presented assumptions 
allow to propose the Cu(II) {2NIm, 2N−am}/Zn(II){2NIm, 
 2H2O} binding modes of both metal ions in the  [CuZnL]4+ 
species.
The formation of next two complexes,  [CuZnH-1L]3+ 
and  [CuZnH-2L]2+ does not significantly influence the 
spectral abilities of the system (Fig. 3; Table 2). It supports 
the same coordination sphere of copper (II) ion. The forma-
tion of these species may be addressed to proton dissocia-
tion from water molecules bound to Zn(II) ion and forma-
tion the hydroxo complexes: [CuZnL(OH−)(H2O)]3+ and 
[CuZnL(OH−)2]2+. The value of logKCuZnL → CuZnH-1L = 7.34 
for proton dissociation from first  H2O molecule is relatively 
low but it is probably connected to the hydrolityc activity 
of Zn(II) complexes (Jakab et al. 2008; Kallay et al. 2009; 
Valensin et al. 2009).
With the increase of the pH, the next proton dissociates 
from the  [CuZnH-2L]2+ complex and the  [CuZnH-3L]+ spe-
cies appears in the system and the spectral abilities of the 
system are changing (Table 2; Fig. 3). The CD parameters 
are comparable to those obtained for the copper complexes 
with one imidazole and three amide donors in the plane: 
{NIm, 3N−am} found in the system with the equimolar con-
ditions (Kotynia et  al. 2014). Due to this fact, the Cu(II) 
{NIm, 3N−am}/Zn(II){2NIm,  2OH−}binding mode can be 
proposed for discussed species.
As the last, two complexes,  [CuZnH-4L] and 
 [CuZnH-5L]−exists in the system. Their formation is con-
nected to the proton dissociation from side chain amino 
groups of both Lys amino acid residues what is supported 
by the values of the logKCuZn-3L→CuZnH-4L = 9.78 and 
logKCuZn-4L→CuZnH-5L = 10.59 (Table 1), however the coordi-
nation sphere of both metals does not change.
In order to analyze the structural aspects of binding 
properties of c(HKHGPG)2 towards copper (II) and zinc 
(II) ions the molecular modeling studies were performed. 
The possible conformations of Cu(II)/c(HKHGPG)2/Zn(II) 
complexes at different pH were optimized at PM6 level 
of theory leading to many unique conformations. In this 
paragraph, we report only on the most stable conformers 
of Cu(II)/c(HKHGPG)2/Zn(II)-peptide complexes in differ-
ent ligands protonation states. Figure 4 contains the lowest-
energy structures. The obtained structures are characterized 
by structural parameters which are in agreement with data 
obtained from X-ray diffraction measurements collected in 
CSD database (Allen et al. 1983).
The experimental results presented above have shown, 
that the creation of first heteronuclear,  [CuZnL]4+, complex 
is connected with dissociation of two, copper-bound, imi-
dazole donors. Next, the deprotonation and involvement of 
two amide nitrogens in Cu(II) binding lead to the formation 
of the species with the {2NIm, 2N−am} binding mode. More-
over in this complex Zn(II) ion is coordinated by two imi-
dazole nitrogens and two water molecules {2NIm,  2H2O} 
in tetrahedral configuration. Moreover, the formation of 
the next two,  [CuZnH−1L]3+ and  [CuZnH−2L]2+ species 
results from the deprotonation of water molecules bound 
to Zn(II) ion. This process does not influence the structural 
properties of Cu(II) binding mode. The distances Cu–NIm 
and Cu–Namide in considered cases are almost the same and 













According to the potentiometric and spectro-
scopic results, the last calculated structure was the 
 [CuZnH− 3L]+structure, in which the Cu(II) ion is coordi-
nated by four nitrogen donors: one  NIm and three amides 
in the plane as it was found in the calculated structure of 
the  [CuH− 3L]+ in copper (II) mononuclear system (Kotynia 
et al. 2014).
Nevertheless, in the case of the Cu(II)/Zn(II) complex 
copper is coordinated by two imidazole and three amide in 
almost tetragonal pyramid configuration.
The Cu,ZnSOD Activity Measurements
The main goal of the presented studies was the investi-
gation of the cyclopeptide as the potential tool for crea-
tion of the mimetics of dinuclear active centers of metal-
loproteins. We have performed the preliminary studies on 
the Cu,ZnSOD activity of three systems with discussed 
cyclopeptide: Cu(II)/c(HKHGPG)2/Zn(II) with the Cu(II) 
{2NIm,  2N−}, {4NIm} binding modes, Cu(II)/c(HKHGPG)2 
with {4NIm} and Cu(II)/c(HKHGPG)2/Cu(II) with {2NIm, 
2 N−}, {2NIm,  2N−}(Kotynia et al. 2014) system at pH 7.4. 
In order to prove that the studied Cu(II)/Zn(II) cyclopep-
tide complexes can decompose the superoxide anion, the 
Cu,ZnSOD activities were investigated by the NBT assay in 
Tris–HCl buffer at physiological pH. The superoxide anion 
was generated in situ by the xanthine/xanthine oxidase 
reaction and spectrophotometrically detected by monitor-
ing the reduction of NBT. The concentrations of the Cu(II) 
and Cu(II)/Zn(II) complexes required to attain 50% inhi-
bition of the reduction (defined as  IC50) were determined. 
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The  IC50 values characterizing the Cu,ZnSOD activity of 
the complexes were calculated based on saturation curves 
(Fig. 5). The greatest activity was observed for the native 
Cu,ZnSOD enzyme, which was taken as the reference point 
for the other measurements. The most efficient complex 
was Cu(II)/(HKHGPG)2/Zn(II) complexes  ([CuZnL]4+). 
Nonetheless, all peptide complexes were found to be redox-
active, demonstrating their effective ability to scavenge the 
Fig. 4  Lowest-energy con-
former of  [CuZnL]4+, [CuZnH-
1L]3+, [CuZnH-2L]2+, [CuZnH-
3L]+ form of c(HKHGPG)2 
peptide obtained using theoreti-
cal calculations. All hydrogens 
atoms are removed for the sake 
of clarity. Copper is shown in 
yellow, zinc in grey, nitrogens in 
cyan, oxygens in red and carbon 
atoms in orange
Fig. 5  Inhibition of the 
nitroblue tetrazolium (NBT) 
reduction by superoxide as a 
function of the concentration 
of  His4-cyclopeptides complex 
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superoxide anion. The  IC50 values as well as their relative 
activity (%) compared to the native Cu,ZnSOD are shown 
in Table 3. The heteronuclear complexes which are domi-
nated in physiological pH have smaller  IC50 value then 
their copper (II) mono- and di-nuclear complexes. What it 
probably cases by binding of Zn(II) ion.
Summary
In this study we presented preliminary results describing the 
ability of the cyclic peptide c(HKHGPG)2 to form Cu(II)/
Zn(II) complexes depending on pH. It has been shown that 
above pH 6 the Cu(II)/Zn(II) heteronuclear complex are 
formed. For  [CuZnL]4+, [CuZnH-1L]3+, [CuZnH-2L]2+, 
[CuZnH-3L]+ species molecular modeling were performed 
in order to characterize the structural aspects of selected 
complexes. The main objective was to verify whether the 
dominant complex at physiological pH may well reproduce 
the active center of Cu,ZnSOD, whether they are able to 
inhibit free radical reaction. Therefore, we examined the 
SOD enzymatic activity for the complexes existing in 7.4 
pH for the following systems: Cu(II)/c(HKHGPG)2/Zn(II), 
Cu(II)/c(HKHGPG)2, and Cu(II)/c(HKHGPG)2/Cu(II). The 
coordination abilities for equimolar and double excess of 
Cu(II) ions have been described and characterized in the 
earlier work (Kotynia et al. 2014). The comparison of the 
 IC50 values of c(HKHGPG)2 complexes in different sys-
tems, shows that the best inhibitory activity of superoxide 
anion exhibits  [CuZnL]4+ complex. This complex domi-
nates in at the physiological range of pH, wherein Cu(II) 
is bound by {2NIm,  2N−} and Zn(II) ions with the {2NIm, 
 2H2O} coordination manner. In systems with only Cu(II) 
ions (at pH 7.4) prevailing species have the same coordina-
tion sphere around Cu(II) ions and the constant stability of 
this complexes are very similar. Therefore, superior enzy-
matic activity can be affected by the simultaneous presence 
of Zn(II) ions in complex.
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